Company news
Dyadic International, Inc. news in 2020
Dyadic International, Inc.'s news releases, calls and decks from 2020, newest first.
Dyadic Announces Third Quarter 2020 Financial Results and Highlights Recent Company Progress
November 11, 2020
Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development
September 16, 2020
Dyadic Announces Second Quarter 2020 Results and Highlights Recent Company Progress
August 12, 2020
Dyadic to Report Second Quarter 2020 Financial Results on Thursday, August 13, 2020
July 29, 2020
Dyadic International Announces Fully Funded Human Health R&D Collaboration with a Top Five Pharmaceutical Company
July 14, 2020
Dyadic Announces Two New Fully Funded Collaborations with Leading Global Animal Health Companies
July 7, 2020
Dyadic Joins Russell 2000(R) Index and Russell 3000(R) Index
June 28, 2020
Dyadic and Frederick National Laboratory to Develop Cell Lines for COVID-19 Vaccine Candidates Using Dyadic's C1 Gene Expression Platform
June 9, 2020
Dyadic Reports 2020 First Quarter Results and Recent Developments
May 13, 2020
Dyadic to Report First Quarter 2020 Financial Results on Thursday, May 14, 2020
April 29, 2020
Dyadic Reports 2019 Year End Results and Recent Developments
March 29, 2020
Dyadic Announces Nonexclusive Research License with WuXi Biologics
March 29, 2020
Dyadic Presents New Business Opportunities to Address COVID-19, Influenza and Continued Scientific and Business Development Progress
March 17, 2020
Dyadic to Report Year End 2019 Financial Results on Monday, March 30, 2020
March 15, 2020
Dyadic and The Israel Institute for Biological Research (IIBR) Expand Collaboration to Combat Emerging Diseases
February 24, 2020
Dyadic Announces New Milestone as G2 Human Like Glycosylation Reached
February 23, 2020
Decks in 2020
- Roth Investor Presentation (March 2020)
Conference · 45 slides · Mar 17, 2020
- Technical Presentation (February 2020)
Technical · 18 slides · Feb 24, 2020